Skip to main navigation Skip to search Skip to main content

Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity

Research output: Contribution to journalArticle

Abstract

: Hematological toxicity following Chimeric Antigen Receptor-T therapy in a patient with a prior allogeneic stem cell transplantation was resolved by the infusion of unselected donor-derived stem cell boost. Due to the donor's lymphocytes, the patient experienced a well-controlled flare-up of acute graft versus host disease.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalAmerican Journal of Hematology
Issue numberJan
DOIs
Publication statusPublished - 2024

All Science Journal Classification (ASJC) codes

  • Hematology

Keywords

  • N/A

Fingerprint

Dive into the research topics of 'Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity'. Together they form a unique fingerprint.

Cite this